Date of Presentation
5-4-2023 12:00 AM
College
School of Osteopathic Medicine
Poster Abstract
Extensive research on neurotypical (NT) populations has demonstrated that a chronically elevated level of serum C Reactive Protein (CRP) is a strong predictor of future cardiovascular disease (CVD). Interestingly, many neurodivergent (ND) populations experience chronically elevated CRP levels higher than NT controls. Current research is concerned with establishing the significance of this relationship to accurately predict CVD risk for potentially at risk ND patients. To contribute to this gap in knowledge, the Rowan-Virtua Regional Integrated Special Needs (RISN) Center patient population will be studied to identify trends in baseline serum CRP levels across a multitude of ND conditions. A clinical risk assessment scale, specifically designed for treating ND populations, will be developed based on the significance of the results of this study.
Keywords
C-Reactive Protein, Cardiovascular Diseases, Neurodivergent, Risk Assessment, Developmental Disabilities, Mental Disorders
Disciplines
Cardiology | Community Health and Preventive Medicine | Health and Medical Administration | Medical Biochemistry | Medicine and Health Sciences | Physiological Processes | Preventive Medicine
Document Type
Poster
Included in
Cardiology Commons, Community Health and Preventive Medicine Commons, Health and Medical Administration Commons, Medical Biochemistry Commons, Physiological Processes Commons, Preventive Medicine Commons
The Correlation Between Serum C-Reactive Protein Level and Risk of Future Cardiovascular Disease: A Neurodivergent Population Dilemma
Extensive research on neurotypical (NT) populations has demonstrated that a chronically elevated level of serum C Reactive Protein (CRP) is a strong predictor of future cardiovascular disease (CVD). Interestingly, many neurodivergent (ND) populations experience chronically elevated CRP levels higher than NT controls. Current research is concerned with establishing the significance of this relationship to accurately predict CVD risk for potentially at risk ND patients. To contribute to this gap in knowledge, the Rowan-Virtua Regional Integrated Special Needs (RISN) Center patient population will be studied to identify trends in baseline serum CRP levels across a multitude of ND conditions. A clinical risk assessment scale, specifically designed for treating ND populations, will be developed based on the significance of the results of this study.